Lataa…
Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
Pancreatic cancer is difficult to diagnose at the initial stage and is often discovered after metastasis to nearby organs. Gemcitabine is currently used as a standard treatment for pancreatic cancer. However, since chemotherapy for pancreatic cancer has not yet reached satisfactory therapeutic resul...
| Päätekijät: | , , , , , , |
|---|---|
| Aineistotyyppi: | Online Artikkeli Teksti |
| Kieli: | English |
| Julkaistu: |
Nature Publishing Group UK
2023
|
| Aiheet: | |
| Linkit: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10175562/ https://www.ncbi.nlm.nih.gov/pubmed/37169953 http://dx.doi.org/10.1038/s41598-023-34827-z |